Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program
==========================================================================================================================================================================================================

* Elena Verzoni
* Giacomo Cartenì
* Enrico Cortesi
* Diana Giannarelli
* Andrea De Giglio
* Roberto Sabbatini
* Sebastiano Buti
* Sabrina Rossetti
* Francesco Cognetti
* Francesca Rastelli
* Alberto Sobrero
* Daniele Turci
* Cora N. Sternberg
* Camillo Porta
* Federico Cappuzzo
* Giampaolo Tortora
* Davide Tassinari
* Stefano Panni
* Antonio Pazzola
* Gianmarco Surico
* Alessandra Raimondi
* Ugo De Giorgi
* Giuseppe Procopio
* on behalf of the Italian Nivolumab Renal Cell Cancer Early Access Program group